Status:
COMPLETED
Randomized Study on Effects of Uniportal VATS Versus Triportal VATS
Lead Sponsor:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions:
Lung Cancer
Eligibility:
All Genders
30-80 years
Brief Summary
For the treatment of stage I-II NSCLC, two mini-invasive techniques are mostly utilized: uni-portal and three-portal VATS. In the uniportal approach, the injury on a single intercostal space could det...
Detailed Description
Randomized cohort clinical trial, prospectic, monocentric. Procedure of randomization: the day before the operation, with the "Random Allocation Rule" technique Arm 1: pulmonary lobectomy and lymphoa...
Eligibility Criteria
Inclusion
- Patients with cT1-2N0-1M0 NSCLC, maximum diameter 5cm
- ASA (American Society of Anestesiology) score 1-2-3
Exclusion
- N2-N3 disease
- Induction chemotherapy
- Thoracic wall infiltration
- Previous thoracic surgery
- Important pleural adhesions
- Severe COPD, asthma, interstitial lung disease - Liver, kidney or cardiac failure
- Clotting disorders
- Analgesic allergy
- Sublobar resection, sleeve lobectomy, pneumonectomy
- Chronic analgesic, oppioids or cortisonic use
- Absence of informed consent
Key Trial Info
Start Date :
March 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03240250
Start Date
March 12 2017
End Date
October 1 2020
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thoracic Surgery Unit - Fondazione IRCCS Ca' Granda Policlinico
Milan, Mi, Italy, 20100